hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis

Manel Esteller, Lluis Catasus, Xavier Matias-Guiu, George L. Mutter, Jaime Prat, Stephen B Baylin, James G. Herman

Research output: Contribution to journalArticle

Abstract

It has recently been suggested that silencing of the hMLH1 gene by promoter hypermethylation is the mechanism underlying the presence of the microsatellite instability (MSI) phenotype in sporadic colon and endometrial carcinomas. To determine whether hMLH1 promoter hypermethylation is a relatively early event in endometrial tumorigenesis we evaluated endometrial hyperplasia (EH) characterized as simple, complex, and atypical (the direct precursor of endometrial carcinoma) for hMLH1 aberrant methylation. In addition, we studied the hMLH1, hMSH2, hMSH3, and hMSH6 promoter methylation and MSI status of those endometrial carcinomas with synchronous hyperplasias and those without them. We found that 11 of 12 (91%) cases of endometrial carcinoma (EC) displaying MSI had hMLH1 promoter hypermethylation, whereas aberrant methylation of any of the other mismatch repair genes was not observed. All 15 cases of EC without MSI were unmethylated at hMLH1. Abnormal methylation of hMLH1 was also present in 8 of 116 (7%) cases of EH and was restricted primarily to the atypical endometrial hyperplasia (AEH) type with coexisting endometrial carcinoma. In this set, half of EH methylated at hMLH1 displayed MSI, whereas none of the unmethylated EH had MSI. Our data suggest that hypermethylation of hMLH1 can be an early event in the pathogenesis of EC, preceding the development of an apparent MSI phenotype in a subset of cases.

Original languageEnglish (US)
Pages (from-to)1767-1772
Number of pages6
JournalAmerican Journal of Pathology
Volume155
Issue number5
StatePublished - Nov 1999

Fingerprint

Microsatellite Instability
Endometrial Neoplasms
Endometrial Hyperplasia
Carcinogenesis
Methylation
Phenotype
DNA Mismatch Repair
Gene Silencing
Hyperplasia
Colon
Genes

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Esteller, M., Catasus, L., Matias-Guiu, X., Mutter, G. L., Prat, J., Baylin, S. B., & Herman, J. G. (1999). hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. American Journal of Pathology, 155(5), 1767-1772.

hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. / Esteller, Manel; Catasus, Lluis; Matias-Guiu, Xavier; Mutter, George L.; Prat, Jaime; Baylin, Stephen B; Herman, James G.

In: American Journal of Pathology, Vol. 155, No. 5, 11.1999, p. 1767-1772.

Research output: Contribution to journalArticle

Esteller, M, Catasus, L, Matias-Guiu, X, Mutter, GL, Prat, J, Baylin, SB & Herman, JG 1999, 'hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis', American Journal of Pathology, vol. 155, no. 5, pp. 1767-1772.
Esteller M, Catasus L, Matias-Guiu X, Mutter GL, Prat J, Baylin SB et al. hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. American Journal of Pathology. 1999 Nov;155(5):1767-1772.
Esteller, Manel ; Catasus, Lluis ; Matias-Guiu, Xavier ; Mutter, George L. ; Prat, Jaime ; Baylin, Stephen B ; Herman, James G. / hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. In: American Journal of Pathology. 1999 ; Vol. 155, No. 5. pp. 1767-1772.
@article{aa8fcce56b0d4bf98adc5a3b718535d8,
title = "hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis",
abstract = "It has recently been suggested that silencing of the hMLH1 gene by promoter hypermethylation is the mechanism underlying the presence of the microsatellite instability (MSI) phenotype in sporadic colon and endometrial carcinomas. To determine whether hMLH1 promoter hypermethylation is a relatively early event in endometrial tumorigenesis we evaluated endometrial hyperplasia (EH) characterized as simple, complex, and atypical (the direct precursor of endometrial carcinoma) for hMLH1 aberrant methylation. In addition, we studied the hMLH1, hMSH2, hMSH3, and hMSH6 promoter methylation and MSI status of those endometrial carcinomas with synchronous hyperplasias and those without them. We found that 11 of 12 (91{\%}) cases of endometrial carcinoma (EC) displaying MSI had hMLH1 promoter hypermethylation, whereas aberrant methylation of any of the other mismatch repair genes was not observed. All 15 cases of EC without MSI were unmethylated at hMLH1. Abnormal methylation of hMLH1 was also present in 8 of 116 (7{\%}) cases of EH and was restricted primarily to the atypical endometrial hyperplasia (AEH) type with coexisting endometrial carcinoma. In this set, half of EH methylated at hMLH1 displayed MSI, whereas none of the unmethylated EH had MSI. Our data suggest that hypermethylation of hMLH1 can be an early event in the pathogenesis of EC, preceding the development of an apparent MSI phenotype in a subset of cases.",
author = "Manel Esteller and Lluis Catasus and Xavier Matias-Guiu and Mutter, {George L.} and Jaime Prat and Baylin, {Stephen B} and Herman, {James G.}",
year = "1999",
month = "11",
language = "English (US)",
volume = "155",
pages = "1767--1772",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis

AU - Esteller, Manel

AU - Catasus, Lluis

AU - Matias-Guiu, Xavier

AU - Mutter, George L.

AU - Prat, Jaime

AU - Baylin, Stephen B

AU - Herman, James G.

PY - 1999/11

Y1 - 1999/11

N2 - It has recently been suggested that silencing of the hMLH1 gene by promoter hypermethylation is the mechanism underlying the presence of the microsatellite instability (MSI) phenotype in sporadic colon and endometrial carcinomas. To determine whether hMLH1 promoter hypermethylation is a relatively early event in endometrial tumorigenesis we evaluated endometrial hyperplasia (EH) characterized as simple, complex, and atypical (the direct precursor of endometrial carcinoma) for hMLH1 aberrant methylation. In addition, we studied the hMLH1, hMSH2, hMSH3, and hMSH6 promoter methylation and MSI status of those endometrial carcinomas with synchronous hyperplasias and those without them. We found that 11 of 12 (91%) cases of endometrial carcinoma (EC) displaying MSI had hMLH1 promoter hypermethylation, whereas aberrant methylation of any of the other mismatch repair genes was not observed. All 15 cases of EC without MSI were unmethylated at hMLH1. Abnormal methylation of hMLH1 was also present in 8 of 116 (7%) cases of EH and was restricted primarily to the atypical endometrial hyperplasia (AEH) type with coexisting endometrial carcinoma. In this set, half of EH methylated at hMLH1 displayed MSI, whereas none of the unmethylated EH had MSI. Our data suggest that hypermethylation of hMLH1 can be an early event in the pathogenesis of EC, preceding the development of an apparent MSI phenotype in a subset of cases.

AB - It has recently been suggested that silencing of the hMLH1 gene by promoter hypermethylation is the mechanism underlying the presence of the microsatellite instability (MSI) phenotype in sporadic colon and endometrial carcinomas. To determine whether hMLH1 promoter hypermethylation is a relatively early event in endometrial tumorigenesis we evaluated endometrial hyperplasia (EH) characterized as simple, complex, and atypical (the direct precursor of endometrial carcinoma) for hMLH1 aberrant methylation. In addition, we studied the hMLH1, hMSH2, hMSH3, and hMSH6 promoter methylation and MSI status of those endometrial carcinomas with synchronous hyperplasias and those without them. We found that 11 of 12 (91%) cases of endometrial carcinoma (EC) displaying MSI had hMLH1 promoter hypermethylation, whereas aberrant methylation of any of the other mismatch repair genes was not observed. All 15 cases of EC without MSI were unmethylated at hMLH1. Abnormal methylation of hMLH1 was also present in 8 of 116 (7%) cases of EH and was restricted primarily to the atypical endometrial hyperplasia (AEH) type with coexisting endometrial carcinoma. In this set, half of EH methylated at hMLH1 displayed MSI, whereas none of the unmethylated EH had MSI. Our data suggest that hypermethylation of hMLH1 can be an early event in the pathogenesis of EC, preceding the development of an apparent MSI phenotype in a subset of cases.

UR - http://www.scopus.com/inward/record.url?scp=0032706744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032706744&partnerID=8YFLogxK

M3 - Article

C2 - 10550333

AN - SCOPUS:0032706744

VL - 155

SP - 1767

EP - 1772

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 5

ER -